PURE Bioscience, Inc.
    SEC Filings

    |
    |

    All SEC filings by PURE Bioscience, Inc. (PURE) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.

    Financials

    10-QQuarterly reportView DiffJun 15, 2026
    10-QQuarterly reportView DiffMar 16, 2026
    10-QQuarterly reportView DiffDec 15, 2025
    10-KAnnual reportView DiffOct 29, 2025
    10-QQuarterly reportView DiffJun 16, 2025
    10-QQuarterly reportView DiffMar 17, 2025
    10-QQuarterly reportView DiffDec 16, 2024
    10-KAnnual reportView DiffOct 29, 2024
    10-QQuarterly reportView DiffJun 14, 2024
    10-QQuarterly reportView DiffMar 18, 2024

    Events

    8-KCurrent reportJun 15, 2026
    8-KEntry Into a Material Definitive AgreementMay 5, 2026
    8-KPure Bioscience Reports Fiscal Second Quarter 2026Mar 16, 2026
    8-KSubmission of Matters to a Vote of Security HoldersFeb 20, 2026
    8-KPure Bioscience Reports Fiscal First Quarter 2026Dec 15, 2025
    8-KPure Bioscience, Inc. Announces Leadership PromotionsNov 19, 2025
    8-KPure Bioscience Reports Fiscal 2025Oct 29, 2025
    8-KPure Bioscience Reports Fiscal Third Quarter 2025Jun 16, 2025
    8-KPure Bioscience Reports Fiscal Second Quarter 2025Mar 17, 2025
    8-KSubmission of Matters to a Vote of Security HoldersJan 28, 2025

    Registrations and Prospectuses

    S-8Registration of securities for employeesAug 15, 2024
    S-8Registration of securities for employeesJan 26, 2022
    POS AMProspectus update (post-effective amendment)Oct 19, 2020
    424B3Prospectus supplementJun 15, 2020
    424B3Prospectus supplementMar 13, 2020
    424B3Prospectus supplementDec 17, 2019
    POS AMProspectus update (post-effective amendment)Oct 31, 2019
    424B3Prospectus supplementJun 14, 2019
    424B3Prospectus supplementMar 7, 2019
    424B3Prospectus supplementDec 14, 2018

    Proxies

    DEF 14ADefinitive proxyView DiffDec 30, 2025
    PRE 14APreliminary proxyView DiffDec 18, 2025
    DEF 14ADefinitive proxyView DiffDec 12, 2024
    DEF 14ADefinitive proxyView DiffJan 10, 2024
    PRE 14APreliminary proxyDec 19, 2023
    DEF 14ADefinitive proxyView DiffDec 23, 2022
    DEF 14ADefinitive proxyView DiffDec 20, 2021
    DEF 14ADefinitive proxyView DiffDec 8, 2020
    PRE 14APreliminary proxyNov 20, 2020
    DEF 14ADefinitive proxyView DiffDec 20, 2019

    Other

    EFFECTNotice of effectivenessOct 26, 2020
    EFFECTNotice of effectivenessNov 5, 2019
    EFFECTNotice of effectivenessNov 1, 2018
    EFFECTNotice of effectivenessOct 31, 2017
    EFFECTNotice of effectivenessSep 1, 2017
    EFFECTNotice of effectivenessFeb 15, 2017
    EFFECTNotice of effectivenessNov 2, 2015
    EFFECTNotice of effectivenessJan 12, 2015
    CORRESPCorrespondence with SECJan 8, 2015
    CORRESPCorrespondence with SECDec 31, 2014

    Ownership

    3Jeffrey Scott KitchellNov 28, 2025
    4Thomas Richard MyersAug 22, 2024
    4David RendallAug 22, 2024
    4Bernard BlotnerAug 22, 2024
    4Mark Stuart ElliottAug 22, 2024
    4Tom Y LeeAug 22, 2024
    4Robert F BartlettAug 22, 2024
    4Ivan ChenAug 22, 2024
    4Darin ZehrAug 22, 2024
    3Darin ZehrMay 13, 2024